Featured Article
Experimental Opioid Reduces Pain But Is Non-Euphoric
Experimental Opioid Reduces Pain But Is Non-Euphoric

Developer says the new drug reduces pain without creating the euphoria that led to the opioid epidemic Drug developer Nektar Therapeutics has announced positive results from a phase III trial of its experimental opioid painkiller called NKTR-181. The drug “significantly ...

Read More

Blog posts in March

  • In the Media: Recalculating, Radio Shows

    Featured on the Recalculating, Radio Shows, Special Guest is Will Wesch, Director of Admissions at Novus Medical Detox Center, a Joint Commission ...

    View More
  • Edie Falco: Art Mirrors Life

    (Novus writes inspirational stories of people in the news who have overcome addiction. This is not to infer that these people are connected to Novus ...

    View More
  • Report: "Heavy Drinking Days" on the Rise, Says NIAAA

    With all the attention and media coverage on the opioid epidemic these days, we can sometimes forget that the biggest substance use disorder is still ...

    View More
  • In the Media: Radio Interview with Kent Runyon

    Hosted by long-time National Post columnist and editor Matt Gurney, National Post Radio offers smart and authoritative debates, commentary and ...

    View More
  • ER Study: Higher Opioid Prescribing Leads to More Long Term Use and Abuse

    A recent study of the prescribing practices of emergency room physicians clearly shows that the more opioids you prescribe, the more long-term use and ...

    View More
  • In the Media: Cannabinoid-based drug pipeline grows: 4 ways to prepare

    Coverage: "4. Be cautious "There should be significant attention and concern regarding the long-term impact of regular use of any cannabinoid-based ...

    View More

Start Your New Path to Sobriety Today!

    • Please enter your name.
    • This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please enter a message.